Bisphenol A in Chronic Kidney Disease

Artificial Organs

Volumn 37, Issue 3, 2013, Pages 283-290

  Krieter, Detlef H ^a   Canaud, Bernard ^f   Lemke, Horst Dieter ^b   Rodriguez, Annie ^f   Morgenroth, Andreas ^c   von Appen, Kai ^d   Dragoun, Gerd Peter ^e   Wanner, Christoph ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Membrana GmbH   (Germany)

^c Dialysis Center   (Germany)

^d Hamburger Dialyse Lohbrügge   (Germany)

^e KfH Nierenzentrum   (Germany)

^f UNIV MONTPELLIER   (France)

Author keywords

Bisphenol A; Chronic kidney disease; End stage renal disease; Hemodialysis; Protein binding; Toxicity

Indexed keywords

BIOCHEMISTRY; ENDOCRINE DISRUPTERS; ENDOCRINOLOGY; HEMODIALYZERS; MAINTENANCE; PHENOLS; PROTEINS; TOXICITY;

BISPHENOL A; BISPHENOLS-A; CHRONIC KIDNEY DISEASE; END-STAGE RENAL DISEASE; HAEMODIALYSIS; HIGH FLUX; IN-VITRO; PLASMA LEVELS; POLYSULPHONE; PROTEIN-BINDING;

DIALYSIS;

4,4' ISOPROPYLIDENEDIPHENOL; POLYSULFONE;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CROSSOVER PROCEDURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IN VITRO STUDY; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 84874669323     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2012.01556.x     Document Type: Article

References (36)

1. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007;24:139-177.
2. Loganathan SN, Kannan K. Occurrence of bisphenol A in indoor dust from two locations in the eastern United States and implications for human exposures. Arch Environ Contam Toxicol 2011;61:68-73.
3. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature 1999;401:763-764.
4. Richter CA, Birnbaum LS, Farabollini F, etal. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007;24:199-224.
5. Nakagawa Y, Tayama S. Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch Toxicol 2000;74:99-105.
6. Elsby R, Maggs JL, Ashby J, Park BK. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J Pharmacol Exp Ther 2001;297:103-113.
7. Bindhumol V, Chitra KC, Mathur PP. Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 2003;188:117-124.
8. Moriyama K, Tagami T, Akamizu T, etal. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 2002;87:5185-5190.
9. Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 2008;31:194-200.
10. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int J Androl 2008;31:201-208.
11. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009;30:75-95.
12. Hengstler JG, Foth H, Gebel T, etal. Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 2011;41:263-291.
13. Keri RA, Ho SM, Hunt PA, Knudsen KE, Soto AM, Prins GS. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol 2007;24:240-252.
14. Lang IA, Galloway TS, Scarlett A, etal. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008;300:1303-1310.
15. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 2010;5:e8673.
16. Silver MK, O'Neill MS, Sowers MR, Park SK. Urinary bisphenol A and type-2 diabetes in U.S. adults: data from NHANES 2003-2008. PLoS ONE 2011;6:e26868.
17. Wang T, Li M, Chen B, etal. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2011;97:E223-227.
18. Carwile JL, Michels K. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 2011;111:825-830.
19. Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures, III: endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006;147(Suppl.):S56-69.
20. Murakami K, Ohashi A, Hori H, etal. Accumulation of bisphenol A in hemodialysis patients. Blood Purif 2007;25:290-294.
21. You L, Zhu X, Shrubsole MJ, etal. Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect 2011;119:527-533.
22. Haishima Y, Hayashi Y, Yagami T, Nakamura A. Elution of bisphenol-A from hemodialyzers consisting of polycarbonate and polysulfone resins. J Biomed Mater Res 2001;58:209-215.
23. Yamasaki H, Nagake Y, Makino H. Determination of bisphenol A in effluents of hemodialyzers. Nephron 2001;88:376-378.
24. Levey AS, Coresh J, Greene T, etal. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007;53:766-772.
25. Krieter DH, Hackl A, Rodriguez A, etal. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 2010;25:212-218.
26. Daugirdas JT. Physiologic principles and urea kinetic modeling. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis. Part II. Blood-based Therapies, 4th Edition. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2007;25-58.
27. Ohkuma H, Abe K, Ito M, Kokado A, Kambegawa A, Maeda M. Development of a highly sensitive enzyme-linked immunosorbent assay for bisphenol A in serum. Analyst 2002;127:93-97.
28. Yamamoto T, Yasuhara A. Quantities of bisphenol A leached from plastic waste samples. Chemosphere 1999;38:2569-2576.
29. Kang JH, Kondo F, Katayama Y. Human exposure to bisphenol A. Toxicology 2006;226:79-89.
30. Kanno Y, Okada H, Kobayashi T, Takenaka T, Suzuki H. Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients. Ther Apher Dial 2007;11:262-265.
31. Farrell PC, Grib NL, Fry DL, Popovich RP, Broviac JW, Babb AL. A comparison of in vitro and in vivo solutes-protein binding interactions in normal and uremic subjects. Trans Am Soc Artif Intern Organs 1972;18:268-276.
32. Csanády GA, Oberste-Frielinghaus HR, Semder B, Baur C, Schneider KT, Filser JG. Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein. Arch Toxicol 2002;76:299-305.
33. Zhang YL, Zhang X, Fei XC, Wang SL, Gao HW. Binding of bisphenol A and acrylamide to BSA and DNA: insights into the comparative interactions of harmful chemicals with functional biomacromolecules. J Hazard Mater 2010;182:877-885.
34. Sargent JA, Gotch FA. Principles and biophysics of dialysis. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of Renal Function by Dialysis, 4th Edition. Dordrecht/Boston/London: Kluwer, 1996;34-102.
35. Schönfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002;110:A703-707.
36. Shelby MD. NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. NTP CERHR MON 2008;v, vii-ix:1-64 passim.